ArticleMultiple sclerosis journal - experimental, translational and clinical

Real-world experience of fingolimod in patients with multiple sclerosis (MS Fine): An observational study in the UK.

Gordon Mazibrada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.